Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PharmaLink Asia Pacific is a specialized provider of market expansion and commercialization services for the healthcare industry across the Asia-Pacific region. The company focuses on helping pharmaceutical and medical device manufacturers navigate complex regulatory environments and establish a market presence through distribution, sales, and marketing support. In 2015, PharmaLink was acquired by DKSH, a leading Swiss market expansion services group, and its operations were integrated into DKSH's Business Unit Healthcare. Today, the entity continues to facilitate the entry of international healthcare brands into diverse Asian markets, providing end-to-end supply chain and commercial solutions. Its service portfolio includes regulatory affairs, product registration, physician detailing, and pharmacy channel management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PharmaLink Asia Pacific.